Top News

• Makary Warns Illegal Copycat Drugs Will Face Swift Enforcement
• Congress Clarifies Orphan Drug Exclusivity & Generic Transparency
• Trust in FDA and CDC Remains Low After Vaccine Changes
• FDA Flags Manufacturing/Quality Lapses at Ipcas India API Plant
• FDA Removes Use Limitation for Yescarta in Rare Lymphoma
• Breakthrough Status for Sonorous BosSTENT for Pulsatile Tinnitus
• Software Assurance Guidance Supplement
• FDA Updates Safety Labels for Chemo Drugs